T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Stanford University15 enrolled

Overview

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Leukemia, Lymphocytic, Acute

Interventions

bone marrow aspirationPROCEDURE

peripheral blood samplingPROCEDURE

Eligibility

Sex: ALLMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children with newly diagnosed T-cell ALL

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.